Issue 4/2015
Content (9 Articles)
Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key?
Fabio Angeli, Gianpaolo Reboldi
Novel Targets of Drug Treatment for Pulmonary Hypertension
Jian Hu, Qinzi Xu, Charles McTiernan, Yen-Chun Lai, David Osei-Hwedieh, Mark Gladwin
Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)
Sebastian Werth, Tomás Breslin, Fionnuala NiAinle, Jan Beyer-Westendorf
Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-Analysis
Bertrand N. Mukete, Mark Cassidy, Keith C. Ferdinand, Thierry H. Le Jemtel
Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis
Daniel Caldeira, Nilza Gonçalves, Joaquim J. Ferreira, Fausto J. Pinto, João Costa
The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing
Scott E. Kasner, Le Wang, Benjamin French, Steven R. Messe, Richard Horenstein, Emile R. Mohler III, James A. S. Muldowney III, Jonas Ellenberg, Stephen E. Kimmel
Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
Uzoma N. Ibebuogu, Oluwaseyi Bolorunduro, Smith Giri, Sam Dagogo-Jack, Blake G. Smith, Saibal Kar, Guy L. Reed
Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
Uzoma N. Ibebuogu, Oluwaseyi Bolorunduro, Smith Giri, Sam Dagogo-Jack, Blake G. Smith, Saibal Kar, Guy L. Reed
Blood Urea Nitrogen/Creatinine Ratio and Response to Tolvaptan in Patients with Decompensated Heart Failure: A Retrospective Analysis
Dai Okayama, Tsuyoshi Suzuki, Tsuyoshi Shiga, Yuichiro Minami, Shuichi Tsuruoka, Nobuhisa Hagiwara